64 related articles for article (PubMed ID: 8547646)
1. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs.
Brooks SC; Kazmer S; Levin AA; Yen A
Blood; 1996 Jan; 87(1):227-37. PubMed ID: 8547646
[TBL] [Abstract][Full Text] [Related]
2. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled.
Chapellier B; Mark M; Messaddeq N; Calléja C; Warot X; Brocard J; Gérard C; Li M; Metzger D; Ghyselinck NB; Chambon P
EMBO J; 2002 Jul; 21(13):3402-13. PubMed ID: 12093741
[TBL] [Abstract][Full Text] [Related]
3. Metabolism to a response pathway selective retinoid ligand during axial pattern formation.
Pijnappel WW; Folkers GE; de Jonge WJ; Verdegem PJ; de Laat SW; Lugtenburg J; Hendriks HF; van der Saag PT; Durston AJ
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15424-9. PubMed ID: 9860984
[TBL] [Abstract][Full Text] [Related]
4. Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: possibly the true retinoid receptor.
Hashimoto Y; Kagechika H; Kawachi E; Shudo K
Jpn J Cancer Res; 1988 Apr; 79(4):473-83. PubMed ID: 2838445
[TBL] [Abstract][Full Text] [Related]
5. The proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids.
Andela VB; Rosier RN
Mol Cancer; 2004 Mar; 3():8. PubMed ID: 15035668
[TBL] [Abstract][Full Text] [Related]
6. Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma.
Viragova S; Aparicio L; Palmerini P; Zhao J; Valencia Salazar LE; Schurer A; Dhuri A; Sahoo D; Moskaluk CA; Rabadan R; Dalerba P
J Natl Cancer Inst; 2023 Jul; 115(7):838-852. PubMed ID: 37040084
[TBL] [Abstract][Full Text] [Related]
7. Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic acid (CD3254).
Jurutka PW; Kaneko I; Yang J; Bhogal JS; Swierski JC; Tabacaru CR; Montano LA; Huynh CC; Jama RA; Mahelona RD; Sarnowski JT; Marcus LM; Quezada A; Lemming B; Tedesco MA; Fischer AJ; Mohamed SA; Ziller JW; Ma N; Gray GM; van der Vaart A; Marshall PA; Wagner CE
J Med Chem; 2013 Nov; 56(21):8432-54. PubMed ID: 24180745
[TBL] [Abstract][Full Text] [Related]
8. Modeling and analysis of retinoic acid induced differentiation of uncommitted precursor cells.
Tasseff R; Nayak S; Song SO; Yen A; Varner JD
Integr Biol (Camb); 2011 May; 3(5):578-91. PubMed ID: 21437295
[TBL] [Abstract][Full Text] [Related]
9. Neurogenesis in Response to Synthetic Retinoids at Different Temporal Scales.
Haffez H; Khatib T; McCaffery P; Przyborski S; Redfern C; Whiting A
Mol Neurobiol; 2018 Mar; 55(3):1942-1950. PubMed ID: 28244006
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Retinoic Acid on Arsenite-Transformed Malignant UROtsa Bladder Cancer Cells: In Vitro Model of Basal Muscle-Invasive Bladder Cancer.
Al-Marsoummi S; Mehus AA; Garrett SH; Sens DA; Somji S
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539513
[TBL] [Abstract][Full Text] [Related]
11. Scaffold hopping from synthetic RXR modulators by virtual screening and
Merk D; Grisoni F; Friedrich L; Gelzinyte E; Schneider G
Medchemcomm; 2018 Aug; 9(8):1289-1292. PubMed ID: 30151082
[TBL] [Abstract][Full Text] [Related]
12. Cell Surface Hsp90- and αMβ2 Integrin-Mediated Uptake of Bacterial Flagellins to Activate Inflammasomes by Human Macrophages.
Hoang TX; Kim JY
Cells; 2022 Sep; 11(18):. PubMed ID: 36139453
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the novel partners of nuclear c-Raf and its role in all-trans retinoic acid (ATRA)-induced myeloblastic leukemia cells differentiation.
Rashid A; Wang R; Zhang L; Yue J; Yang M; Yen A
Exp Cell Res; 2020 Sep; 394(1):111989. PubMed ID: 32283065
[TBL] [Abstract][Full Text] [Related]
14. Roscovitine enhances all-
Rashid A; Duan X; Gao F; Yang M; Yen A
Oncotarget; 2020 Mar; 11(12):1017-1036. PubMed ID: 32256976
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML.
Bunaciu RP; MacDonald RJ; Jensen HA; Gao F; Wang X; Johnson L; Varner JD; Yen A
Leuk Lymphoma; 2019 Jul; 60(7):1697-1708. PubMed ID: 30570341
[TBL] [Abstract][Full Text] [Related]
16. An Effective Model of the Retinoic Acid Induced HL-60 Differentiation Program.
Tasseff R; Jensen HA; Congleton J; Dai D; Rogers KV; Sagar A; Bunaciu RP; Yen A; Varner JD
Sci Rep; 2017 Oct; 7(1):14327. PubMed ID: 29085021
[TBL] [Abstract][Full Text] [Related]
17. RRD-251 enhances all-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.
Wallace AS; Supnick HT; Bunaciu RP; Yen A
Oncotarget; 2016 Jul; 7(29):46401-46418. PubMed ID: 27331409
[TBL] [Abstract][Full Text] [Related]
18. 6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.
Bunaciu RP; Jensen HA; MacDonald RJ; LaTocha DH; Varner JD; Yen A
PLoS One; 2015; 10(8):e0135668. PubMed ID: 26287494
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blasts.
Jensen HA; Bunaciu RP; Ibabao CN; Myers R; Varner JD; Yen A
PLoS One; 2014; 9(6):e98929. PubMed ID: 24922062
[TBL] [Abstract][Full Text] [Related]
20. 6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.
Bunaciu RP; Yen A
Mol Cancer; 2013 May; 12():39. PubMed ID: 23656719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
